Induction of Immune Tolerance in Islet Transplantation Using Apoptotic Donor Leukocytes
Allogeneic islet transplantation has become an effective treatment option for severe Type 1 diabetes with intractable impaired awareness due to hypoglycemic events. Although current immunosuppressive protocols effectively prevent the acute rejection associated with initial T cell activation in recip...
Enregistré dans:
Auteurs principaux: | Naoya Sato, Shigeru Marubashi |
---|---|
Format: | article |
Langue: | EN |
Publié: |
MDPI AG
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/e9218a7a69e449feaf66c1cfcf1f39c7 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Single-donor islet transplantation in type 1 diabetes: patient selection and special considerations
par: Tatum JA, et autres
Publié: (2017) -
Second hematopoietic stem cell transplantation with a new haploid-mismatched donor in relapsed patients after first transplantation: prognostic analysis of 11 cases
par: ZHU Panpan, et autres
Publié: (2021) -
Islet Transplantation Imaging in vivo
par: Zheng L, et autres
Publié: (2020) -
Safety, clinical and laboratory characteristics of donors with thalassemia minor in living donor kidney transplant: a case series
par: Nhan Hieu Dinh, et autres
Publié: (2021) -
Donor-transmitted melanoma after limbal stem cell transplantation
par: Anas Alsara, et autres
Publié: (2017)